Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 21392421)

1.

Rapid molecular detection of tuberculosis and rifampin resistance.

Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD.

N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.

2.

Tuberculosis control and elimination 2010-50: cure, care, and social development.

Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC.

Lancet. 2010 May 22;375(9728):1814-29. doi: 10.1016/S0140-6736(10)60483-7.

PMID:
20488524
3.

Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection.

Coggin WL, Ryan CA, Holmes CB.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S255-9. doi: 10.1086/651499. Review.

4.

Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis.

Burman WJ, Bliven EE, Cowan L, Bozeman L, Nahid P, Diem L, Vernon A; Tuberculosis Trials Consortium.

Emerg Infect Dis. 2009 Jul;15(7):1061-7. doi: 10.3201/eid1507.081253.

5.

Global investments in TB control: economic benefits.

Laxminarayan R, Klein EY, Darley S, Adeyi O.

Health Aff (Millwood). 2009 Jul-Aug;28(4):w730-42. doi: 10.1377/hlthaff.28.4.w730. Epub 2009 Jun 30.

6.

Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients.

Pantoja A, Floyd K, Unnikrishnan KP, Jitendra R, Padma MR, Lal SS, Uplekar M, Chauhan LS, Kumar P, Sahu S, Wares F, Lönnroth K.

Int J Tuberc Lung Dis. 2009 Jun;13(6):698-704.

PMID:
19460244
7.

Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.

Ling DI, Flores LL, Riley LW, Pai M.

PLoS One. 2008 Feb 6;3(2):e1536. doi: 10.1371/journal.pone.0001536.

8.

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.

Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME.

Am J Respir Crit Care Med. 2008 Apr 1;177(7):787-92. doi: 10.1164/rccm.200709-1436OC. Epub 2008 Jan 17.

PMID:
18202343
9.
10.

International standards for tuberculosis care.

Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC.

Lancet Infect Dis. 2006 Nov;6(11):710-25. Review.

PMID:
17067920
11.
13.

WHO's new Stop TB Strategy.

Raviglione MC, Uplekar MW.

Lancet. 2006 Mar 18;367(9514):952-5. No abstract available.

PMID:
16546550
14.

REALISTIC CHEMOTHERAPEUTIC POLICIES FOR TUBERCULOSIS IN THE DEVELOPING COUNTRIES.

FOX W.

Br Med J. 1964 Jan 18;1(5376):135-42. No abstract available.

15.

A plan for the eradication of syphilis.

BROWN WJ.

South Med J. 1963 Aug;56:840-3. No abstract available.

PMID:
14016053
17.

Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches.

García de Viedma D.

Clin Microbiol Infect. 2003 May;9(5):349-59. Review.

18.

Treatment of tuberculosis.

American Thoracic Society; CDC; Infectious Diseases Society of America.

MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77. No abstract available. Erratum in: MMWR Recomm Rep. 2005 Jan 7;53(51):1203. Dosage error in article text.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk